TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Research and development spending
3Y CAGR
+23.8%/yr
Annual compound
5Y CAGR
+40.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.5x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $113.56M | +5.8% |
| 2024 | $107.35M | +21.8% |
| 2023 | $88.15M | +47.4% |
| 2022 | $59.82M | +33.1% |
| 2021 | $44.95M | +118.5% |
| 2020 | $20.58M | +117.9% |
| 2019 | $9.44M | - |